• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REVISION OPTICS, INC. RAINDROP NEAR VISION INLAY; CORNEAL INLAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REVISION OPTICS, INC. RAINDROP NEAR VISION INLAY; CORNEAL INLAY Back to Search Results
Model Number 610-0001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Clouding/Hazing (1878); Loss of Vision (2139)
Event Date 09/20/2017
Event Type  Injury  
Manufacturer Narrative
The explanted inlay was returned to the manufacturer and subjected to visual microscopic inspection and dimensional analysis.The edge thickness and diameter were measured and found to be within specifications.A small portion near the inlay edge was torn off and some particles were present on the surface, but these findings are consistent with findings for corneal inlays that have been explanted since surgical instruments are required to remove the device from the eye and place it in a hydrated storage container for transport.The device history record review of the manufacturing lot was performed and there were no discrepancies or unusual findings related to the reported issue.Corneal haze is listed in the device labeling as a known potential risk.Complaint reference #: (b)(4).
 
Event Description
The patient underwent implantation of the raindrop corneal inlay in the right eye on (b)(6) 2017.Two months postoperatively the patient presented with corneal haze that did not respond to treatment with durezol and the inlay was explanted on (b)(6) 2017.The type of haze and impact on vision is not known at this time.Additional information is being requested.
 
Manufacturer Narrative
Decreased visual acuity is listed in the device labeling as a known potential risk.(b)(4).
 
Event Description
Patient follow-up was requested from the surgeon, who provided the following additional information.There were no complications during surgery to implant the inlay, and the patient had no pre-existing conditions.Six weeks postoperatively the patient presented with grade 2+ corneal haze on the edge of the inlay.The corneal haze was associated with a decrease in best corrected distance visual acuity (bcdva) from 20/20 (preoperatively) to 20/40 (at first onset), improving to 20/25 immediately prior to inlay explantation.Post inlay explant, the corneal haze has resolved with 20/25 bcdva.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
CORNEAL INLAY
Manufacturer (Section D)
REVISION OPTICS, INC.
25651 atlantic ocean drive
suite a1
lake forest CA 92630 8835
Manufacturer (Section G)
REVISION OPTICS, INC.
25651 atlantic ocean drive
suite a1
lake forest CA 92630 8835
Manufacturer Contact
pushpita singh
25651 atlantic ocean drive
suite a1
lake forest, CA 92630-8835
9497072740
MDR Report Key6963664
MDR Text Key89816625
Report Number3005956347-2017-00123
Device Sequence Number1
Product Code LQE
UDI-Device Identifier10850394006013
UDI-Public(01)10850394006013
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 12/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date11/22/2019
Device Model Number610-0001
Device Catalogue NumberRD1-1
Device Lot Number003045
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/29/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/20/2017
Initial Date FDA Received10/19/2017
Supplement Dates Manufacturer Received09/20/2017
Supplement Dates FDA Received12/20/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/22/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
-
-